Liver transplantation of patients with cryptogenic cirrhosis: Clinical characteristics and outcome

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 1, 2010, Pages 60-69

  Marmur, Joel ^a   Bergquist, Annika ^b   Såtl, Per ^b  

^a ERSTA HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cryptogenic cirrhosis; Liver transplantation; Non alcohol fatty liver disease; Survival

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; CRYPTOGENIC CIRRHOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPONATREMIA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; NONALCOHOLIC FATTY LIVER; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL; WEIGHT REDUCTION;

ADULT; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 73649143497     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903384742     Document Type: Article

References (26)

1. Sutedja DS, Gow PJ, Hubscher SG, Elias E. Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy. Transplant Proc 2004;36:2334-2337
2. Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, et al. Cryptogenic cirrhosis: Clinicopathologic findings at and after liver ransplantation. Hum Pathol 2002;33:1098-1104
3. Duclos-Valée J-C, Yilmaz F, Johanet C, Roque-Afonso A-M, Gigou M, Trichet C, et al. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? Clin Transpl 2005;19:591-599
4. Contos MJ, Cales W, Sterling RK, Luketic VA, Mitchell L, Shiffman ML, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 2001;7:363-373
5. Heringlake S, Schütte A, Flemming P, Schmiegel W, Manns MP, Tillmann HL. Presumed cryptogenic liver disease in Germany: high prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology. Z Gastroenterol 2009;47:417-423
6. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis; a case control study. Hepatology 2000;32:689-692
7. Tellez-Avila FI, Sanchez-Avila F, García-Saenz-de-Sicilia M, Chavez-Tapia NC, Franco-Guzman AM, Lopez-Arce G, et al. Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis. World J Gastroenterol 2008;30:4771-4775
8. Henegan MA, Zolfino T, Muiesan P, Portmann BC, Rela M, Heaton ND, et al. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis. Liver Transplant 2003;9:921-928
9. Maheshwari A, Thuluvath PJ. Cryptogenic cirrhosis and NAFLD: Are they related? Am J Gastroenterol 2006;101:664-668
10. Charlton MR, Kondo M, Roberts SK, Steers JL, Krom RA, Wiesner RH. Liver transplantation for cryptogenic cirrhosis. Liver Transplant Surg 1997;3:359-364
11. Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier M-H, et al. Survival, liver failure and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002;35:1485-1493
12. Giannini EG, Marabotto E, Savarino V, Trevisani F, Di Nolfo MA, Del Poggio P, et al. Hepatocellular carcinoma in patients with cryptogenic cirrhosis. Clin Gastroent Hepatol 2009;7:580-585
13. Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J. Outcome after liver transplantation for NASH cirrhosis.Am J Transplant 2009;9:782-793
14. Sanjeevi A, Lyden E, Sunderman B, Weseman R, Ashwathnarayan R , Mukherjee S. Outcomes of liver transplantation for cryptogenic cirrhosis: A single center study of 71 patients. Transplant Proc 2003;35:2977-2980
15. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004;24:3-20.
16. Czaja AJ, Freese DK, American Association for the Study of Liver Disease. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-497
17. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-1362
18. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-669
19. Caldwell SH, Crespo DM. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 2004;40:578-584
20. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-140
21. Clark JM, Diehl AM. Non-alcoholic fatty liver disease: An unrecognized cause of cryptogenic cirrhosis. JAMA 2003;289:3000-3004
22. Mulhall BP, Ong J, Younossi ZM. Non-alcoholic fatty liver disease: An overview. J GastroenterolHepatol 2002;17:1136-1143
23. Ekstedt M, Franzén LR, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-873
24. Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrosis? Hepatology 2002;36:150-155
25. Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Gina Boffo G, et al. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001;17:445-450
26. Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, et al. Long term outcome of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 2003;38:420-427